Bausch + Lomb Corporation operates as an eye health company worldwide.
$19.99+0.35%
报价 2026-11-06
市值
$7.15B
EV
$11.73B
PE (TTM)
–
预期 PE (FY2026)
21.3x
52 周区间距高点 -3.0%
$14.56$20.60
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
电话会信号
辅助标签Q3 20262026-10-28
上调指引
指引 上调
信心 4
分析师 4
“We remain committed to meeting or exceeding the targets we laid out in our 3-year plan.”
原文引用（1）
- 上调指引：we are now raising guidance for the third time this year
蓝色标签在暴涨研究中略有区分度；悬停查看口径。
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Medical - Instruments & Supplies| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| BLCOBausch + Lomb Corporation | $7.15B | +0.4% | +8.2% | 60.5% | – | 17.1x | 28.2x | |
| COOThe Cooper Companies, Inc. | $11.86B | -1.8% | +4.0% | 62.4% | 19.1x | 14.6x | 16.1x | |
| RGENRepligen Corporation | $11.09B | +3.0% | +15.8% | 53.1% | 233.1x | 56.2x | 87.9x | |
| AVTRAvantor, Inc. | $10.48B | +2.2% | +2.2% | 31.5% | 30.9x | 15.1x | 23.9x | |
| ATRAptarGroup, Inc. | $9.03B | -1.1% | +8.7% | 27.8% | 22.0x | 11.1x | 25.3x | |
| TFXTeleflex Incorporated | $6.39B | -0.8% | -30.7% | 53.3% | – | 63.6x | 26.1x | |
| HAEHaemonetics Corporation | $5.46B | -3.4% | +7.0% | 59.8% | 58.9x | 24.8x | 18.9x | |
| MMSIMerit Medical Systems, Inc. | $5.23B | -2.7% | +7.1% | 48.7% | 31.5x | 13.5x | 20.7x | |
| ICUIICU Medical, Inc. | $4.3B | +2.7% | -0.8% | 36.4% | 90.1x | 20.0x | 52.4x | |
| 同行中位数 | – | – | +5.5% | 50.9% | 31.5x | 17.6x | 24.6x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-09-30 Q3 2026 | 2026-06-30 Q2 2026 | 2026-03-31 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-30 Q3 2025 | 2025-06-30 Q2 2025 | 2025-03-31 Q1 2025 | 2024-12-31 Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.38B | $1.39B | $1.24B | $1.41B | $1.28B | $1.28B | $1.14B | $1.28B |
| Gross Margin | 60.5% | 59.1% | 56.6% | 58.1% | 54.9% | 53.7% | 51.7% | 60.9% |
| Operating Margin | 11.3% | 6% | 4.7% | 11.2% | 6.2% | 0.9% | -5.4% | 6.8% |
| Net Income | $32M | $-14M | $-71M | $-58M | $-28M | $-62M | $-212M | $-3M |
| Diluted EPS | 0.09 | -0.04 | -0.2 | -0.16 | -0.08 | -0.18 | -0.6 | -0.01 |
| Operating Cash Flow | $233M | $153M | $32M | $134.3M | $139.1M | $35M | $-25M | $22M |